Mirati Therapeutics, Inc. Profile Avatar - Palmy Investing

Mirati Therapeutics, Inc.

Mirati Therapeutics, Inc., a clinical-stage oncology company, develops product candidates to address the genetic and immunological promoters of cancer in the United States. The company develops MRTX849, a KRAS G12C inhibitor, which is in Phase 1/2 clinic…
Biotechnology
US, San Diego [HQ]
Competitors · Subsidiaries · Locations

Context Analysis

Worldwide · Business Intelligence
U.S. · Business Intelligence
Worldwide · Competitors Table
Worldwide · Subsidiaries Table
Subsidiary Private? Country City
- - - -